about
Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunityPsychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovationsMolecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?The possibility of clinical sequencing in the management of cancerProposing Essential Medicines to Treat Cancer: Methodologies, Processes, and OutcomesPragmatic medicine in solid cancer: a translational alternative to precision medicineA synergetic screening approach with companion effector for combination therapy: application to retinoblastomaPotentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasoundRepositioning approved drugs for the treatment of problematic cancers using a screening approach.Study of the mechanism of sonodynamic therapy in a rat glioma model.Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: a systematic review.Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.LPRP: A Gene-Gene Interaction Network Construction Algorithm and Its Application in Breast Cancer Data Analysis.Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data.The fruits of long endeavors - 200 years of oncology.The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly AustraliansA Review Study on Macrolides Isolated from Cyanobacteria.Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon.Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerToll-like receptor 2 and Toll-like receptor 4-dependent activation of B cells by a polysaccharide from marine fungus Phoma herbarum YS4108The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.Gene therapy for cancer: present status and future perspectiveCircadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer.Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes.MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective.Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.Capability of leaf interdigitation with different inverse planning strategies in Monaco: an investigation of representative tumour sitesICAM-1 +469 A/G polymorphism and cancer risk: a meta-analysis involving 9375 subjects.Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.Identification of differences in immunotherapy knowledge and practice patterns among oncologists from six European countries.Case report of a Li-Fraumeni syndrome-like phenotype with a de novo mutation in CHEK2.Macrophages Polarized by Expression of ToxoGRA15II Inhibit Growth of Hepatic Carcinoma.Quantitative implementation of the endogenous molecular-cellular network hypothesis in hepatocellular carcinoma.Molecular mechanisms of melatonin's inhibitory actions on breast cancers.The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?The role of Chinese medicine in clinical oncology.Evolution of targeted therapies in cancer: opportunities and challenges in the clinic.
P2860
Q26862220-254D4D8C-EEAF-4130-B9BD-3E5B2CE3D043Q27007708-5E2B61A2-766C-4D65-98A8-C4DF86C7FA84Q28068956-B753F382-F5BD-4A36-B24A-35C9C939DF5FQ28072144-BBB99E3C-3700-49C9-9AE3-B2ACA92919C9Q28081319-CA6F6059-EB9B-4832-B002-1AE6F79CD01EQ28391863-CF61BEB3-B4A2-44D8-8B0F-0A7C5C7325CAQ28488349-7D3DC43A-7DBF-4BB6-B548-8DDF2B4A6AB4Q28488824-9A817604-C194-48B3-AE51-1E7EF23F5DF8Q29248487-BF8C4520-9994-48FC-8B35-19E4D9B30305Q30428104-97C4B014-C90C-4E39-9EAC-D01B0C32A0B1Q30827101-DFF5E46F-E8EF-453D-83DF-1407064650E5Q30847275-9ADA0786-B4CA-4565-A0DA-DD6E48EF02C9Q31131478-0F28C1F1-04F6-43DA-9119-7ED9C869D08BQ31132965-14309B25-CED7-4A8B-BD6F-B2F16190DEDAQ33595342-1E23C7D6-0266-4D5E-BC11-0C853B597CA5Q33629327-FE75D7A0-3359-49F7-9D8D-68517A349F13Q33744107-F1394E80-70E3-44FE-98D5-C0A42D7C04AFQ33899089-97C90950-51FC-41D2-A6D8-CFF4E38665AFQ34277777-34F98425-6A4D-4764-9E1B-817869A2DBC1Q34619220-0915725E-E45C-45B5-B677-951CBAF63BE9Q34654099-FAC698CC-FD23-4F21-B557-A2D02FE62B6CQ35173496-4AAE5340-89AE-4BC6-82F9-96E9579EEFD7Q35648976-08775BA1-3C00-495F-A176-BC0B03813246Q35673900-52ABBC47-37BD-40AF-A27F-E9D0FC9CD5C3Q35691235-F59DB689-50C9-42CB-9A9A-A89B3C7BC666Q35749677-DD03C76C-8CC8-4AE4-AF90-D2798D1D1CD4Q36782579-20421655-269F-4BAB-A4FE-9318583B0313Q36964343-31D148A0-4D06-4F8E-A8C3-192294BA2015Q37002698-DC40D0A8-8472-405A-8770-B8A7468CC334Q37018075-56026884-C59B-4A96-8131-E8DF31ECEBBAQ37516341-F7DBC456-8E6E-408A-8BB0-0E70BFBC44C6Q37542216-F5EE384C-FF4C-4A1D-9F1C-4AF6DA1CEECBQ37567788-36D6F1D8-3755-40A6-9D33-96C03DAA1F34Q37605439-450ED984-5D6E-4734-B13D-69320017DA5FQ37637462-4DC53415-5BDA-44C2-BB21-D0B4138F6BDAQ37718332-A25174F4-82C0-44ED-BC27-D318491AAC13Q38046127-9FAD6066-0F2D-46D7-9CC8-D06D1B64E033Q38099237-3BF29EB8-6B8E-4A3D-953E-F792CA49F827Q38152716-90AF37C0-9B93-4EF2-9DD0-AF69D7797288Q38319572-5A708AD5-C1A4-4DA7-9305-39A67F351D11
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Two hundred years of cancer research.
@ast
Two hundred years of cancer research.
@en
Two hundred years of cancer research.
@nl
type
label
Two hundred years of cancer research.
@ast
Two hundred years of cancer research.
@en
Two hundred years of cancer research.
@nl
prefLabel
Two hundred years of cancer research.
@ast
Two hundred years of cancer research.
@en
Two hundred years of cancer research.
@nl
P356
P1476
Two hundred years of cancer research
@en
P2093
Steven A Rosenberg
Vincent T DeVita
P304
P356
10.1056/NEJMRA1204479
P407
P577
2012-05-30T00:00:00Z